Affimed is a clinical-stage immuno-oncology company focused on harnessing the innate immune system to fight cancer.
Affimed has three active clinical programs focused on solid tumors and blood cancers.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Affimed’s Innate Cell Engagers, generated from its ROCK platform, are bispecific antibodies that target innate immune cells, including natural killer cells and macrophages, to destroy tumor cells.
Source: LinkedIn company description · Retrieved October 13, 2026
Its three active clinical programs focus on solid tumors and blood cancers.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 2, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 27, 2026, September 28, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.